Teachers Advisors’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Teachers Advisors’s Portfolio OMED Stock Details OMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-37,167	Closed	-$342K	–	3270
2017 Q1	$342K	Buy	37,167 +6,744	+22%	+$59.2K	﹤0.01%	2704
2016 Q4	$235K	Buy	30,423 +2,961	+11%	+$27.2K	﹤0.01%	2858
2016 Q3	$314K	Hold	27,462	–	–	﹤0.01%	2700
2016 Q2	$338K	Hold	27,462	–	–	﹤0.01%	2631
2016 Q1	$278K	Buy	27,462 +3,165	+13%	+$37.2K	﹤0.01%	2654
2015 Q4	$548K	Hold	24,297	–	–	﹤0.01%	2354
2015 Q3	$403K	Hold	24,297	–	–	﹤0.01%	2516
2015 Q2	$547K	Buy	24,297 +6,684	+38%	+$165K	﹤0.01%	2480
2015 Q1	$454K	Hold	17,613	–	–	﹤0.01%	2480
2014 Q4	$383K	Hold	17,613	–	–	﹤0.01%	2583
2014 Q3	$333K	Hold	17,613	–	–	﹤0.01%	2620
2014 Q2	$410K	Buy	17,613 +11,206	+175%	+$277K	﹤0.01%	2544
2014 Q1	$216K	Hold	6,407	–	–	﹤0.01%	2842
2013 Q4	$189K	Buy	6,407 +1,957	+44%	+$35.9K	﹤0.01%	2884
2013 Q3	$68K	Buy	+4,450	New	+$82.5K	﹤0.01%	3031

Other funds holding OMED

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

ASP

Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

IHM

Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Teachers Advisors's OMED Position: Q2 2017 in Review

Teachers Advisors sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q2 2017, closing a stake of 37,167 shares — an estimated $342K sold.

Teachers Advisors first reported a position in OMED in Q3 2013 and held it in 15 quarters. The position peaked at $548K in Q4 2015. 68 funds tracked by Wall St. Rank hold OMED as of Q2 2017.

Teachers Advisors reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q2 2017 after selling out during the quarter.
Teachers Advisors sold 37,167 OncoMed Pharmaceuticals, Inc. shares in Q2 2017, an estimated $342K.
Teachers Advisors first reported a position in OncoMed Pharmaceuticals, Inc. in Q3 2013 and held it in 15 quarters.
Teachers Advisors's OncoMed Pharmaceuticals, Inc. position peaked at $548K in Q4 2015.
68 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q2 2017.

Based on Teachers Advisors's 13F filing for Q2 2017, filed 10 Aug 2017.